MedPath

Validation of a High-Quality Low-Cost Open-Source Electrocardiograph

Not Applicable
Conditions
Electrocardiograph
Open Access
Medical Devices
Low Cost
Interventions
Device: Medical device validation
Registration Number
NCT04209062
Lead Sponsor
Lawson Health Research Institute
Brief Summary

The high price of electrocardiograph (ECG) devices - with most hospital-grade devices costing thousands of dollars - is one of the barriers to access of this vital technology. There is a shortage of ECG devices in underserved areas and the devices available on the market currently are not adequate to solve this problem. Our solution is a low-cost high-quality open-access ECG device. This study intends to validate the study ECG device in human patients by demonstrating equivalence between the study ECG device and a gold standard device.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
450
Inclusion Criteria
  • All study participants must be able to provide written informed consent prior to study procedure. This study has 2 Phases.

Phase 1:

  • Healthy
  • > 18 years of age

Phase 2:

  • > 18 years of age
  • non critical patients presenting to the emergency department (Victoria Hospital and University Hospital) with cardiac complaint
Exclusion Criteria
  • < 18 years old
  • Unable to consent

Phase 1:

  • > 70 years of age
  • Previous history of cardiac disease (e.g., atrial fibrillation, myocardial infarction, congestive heart failure)
  • current status of non-sinus heart rhythm

Phase 2:

  • Critical patients in the ED where consent would inappropriately delay investigations or treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Control deviceMedical device validation-
Study deviceMedical device validation-
Primary Outcome Measures
NameTimeMethod
Equivalence of Electrical Signals between 3D printed ECG device and Gold Standard ECG60 seconds

Comparing electrical signals from ECG electrodes with tested device and gold standard device by collecting the following data from both devices: rate, QR interval, PR interval, QT interval, and rhythm.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

London Health Sciences Centre

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath